Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-16-004976
Filing Date
2016-04-28
Accepted
2016-04-28 16:35:19
Documents
5
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A bpmc-20160428xdefa14a.htm DEFA14A 54600
2 GRAPHIC bpmc20160428xdefa14a001.gif GRAPHIC 29642
3 GRAPHIC bpmc20160428xdefa14a002.gif GRAPHIC 58515
4 GRAPHIC bpmc20160428xdefa14a003.gif GRAPHIC 12942
5 GRAPHIC bpmc20160428xdefa14a004.gif GRAPHIC 2539
  Complete submission text file 0001558370-16-004976.txt   198307
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37359 | Film No.: 161600609
SIC: 2834 Pharmaceutical Preparations